Page last updated: 2024-10-27

berotek and Brain Neoplasms

berotek has been researched along with Brain Neoplasms in 1 studies

Fenoterol: A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.
fenoterol : A member of the class resorcinols that is 5-(1-hydroxyethyl)benzene-1,3-diol in which one of the methyl hydrogens is replaced by a 1-(4-hydroxyphenyl)propan-2-amino group. A beta2-adrenergic agonist, it is used (as the hydrobromide salt) as a bronchodilator in the management of reversible airway obstruction.

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wnorowski, A1
Such, J1
Paul, RK1
Wersto, RP1
Indig, FE1
Jozwiak, K1
Bernier, M1
Wainer, IW1

Other Studies

1 other study available for berotek and Brain Neoplasms

ArticleYear
Concurrent activation of β
    Cellular signalling, 2017, Volume: 36

    Topics: Animals; Apoptosis; Brain Neoplasms; Carcinogenesis; Cell Cycle; Cell Line, Tumor; Cell Movement; Ce

2017